Tapinarof Demonstrates Efficacy in Patient With Nonulcerated Necrobiosis Lipoidica
In the case of one patient, researchers found that topical tapinarof cream demonstrated therapeutic efficacy in nonulcerated necrobiosis lipoidica.
John Barbieri, MD, MBA, FAAD: Aligning Treatments With Patients' Experiences
John Barbieri, MD, MBA, FAAD, discusses his SDPA Annual Summer Dermatology Conference sessions, "Foundational Tools for Acne and Rosacea Management," and "Neutraceuticals and Cosmeceuticals: Which to Choose?"
Skin Cancer in the Realm of Inflammatory Dermatoses
Darrell Rigel, MD, discusses his SDPA Annual Summer Dermatology Conference, "Inflammatory Dermatoses: A Case-Based Review," particularly highlighting the relationship between skin cancer and the inflammatory disease realm.
Rising Antifungal Resistance Poses a Threat to Onychomycosis Treatment
A poster presented at the 2023 SDPA Annual Summer Dermatology Conference analyzed the growing threat of antifungal resistance, particularly with the treatment of onychomycosis in mind.
Reviewing Considerations for Pigmentary Disorders With Nicole Gunasekera, MD, MBA
Nicole Gunasekera, MD, MBA, presented a session on disorders of pigmentation at the 2023 SDPA Annual Summer Dermatology Conference.
Survey Results Show Moderate to Severe Psoriasis Increases Anxiety and Depression Levels
Researchers evaluated factors affecting quality of life and what to consider when determining a patient’s psoriasis treatment plan.
SDPA Annual Summer Dermatology Conference Recap: Day 1
Catch up on coverage from the first day of the 2023 SDPA Annual Summer Dermatology Conference.
Sights and Sounds of the SDPA Annual Summer Dermatology Conference: Day 1
Catch up on visual highlights and views from the first day of the SDPA Annual Summer Dermatology Conference in Boston, MA.
New and Promising Drugs in Inflammatory Dermatoses
Mark Lebwohl, MD, discusses his SDPA Annual Summer Dermatology Conference session, "Inflammatory Dermatoses: A Case-Based Review."
Tazarotene Led to Hyperpigmentation Improvement in Black Patients With Acne
A poster presented at the 2023 SDPA Annual Summer Dermatology Conference revealed improvements to hyperpigmentation in a cohort of Black patients with moderate-to-severe acne.
Emphasizing Culturally Competent Care in Patients With Skin of Color
Omar Noor, MD, FAAD, discusses cultural competency in caring for patients with skin of color in dermatology.
Brodalumab Demonstrates Quality of Life, Mental Health Improvement in Patients Regardless of Prior Biologic Use
A poster presented at the 2023 SDPA Annual Summer Dermatology Conference revealed statistically significant improvements among patients with psoriasis receiving brodalumab treatment.
Discussing Clinical Pearls in Dermatology With Omar Noor, MD, FAAD
Omar Noor, MD, FAAD, discusses his SDPA session, "Clinical Pearls for Pediatric and Adult Dermatology."
Plan Your Trip: What to do While Visiting Boston
When sessions, late-breaking research, and more conclude, there is no shortage of things to do in historic Boston.
POLL: What Topic Are You Most Looking Forward to at SDPA Summer 2023?
Click here to answer today's poll.
Previewing the SDPA Annual Summer Dermatology Conference: What to Expect
The conference aimed at providing dermatology physician assistants with the latest in the field begins tomorrow in Boston, Massachusetts.
Dermatology Providers Share Their Best Pearls From Fall Clinical for PAs and NPs
Dermatology Times had the opportunity to speak with numerous leading KOLs in the industry, live and virtually, at the 2023 Fall Clinical Dermatology Conference for PAs and NPs.
POLL: Are You Attending SDPA Summer 2023?
Click here to answer this week's poll.
Recap From the 2023 Fall Clinical Dermatology Conference for PAs and NPs
If you weren’t able to attend Fall Clinical for PAs and NPs or want to review our latest coverage and interviews, our full recap has you covered.
Tazarotene 0.045% Lotion for Acne Safe, Improves Hyperpigmentation in SOC Patients
A poster presentation from the Fall Clinical Dermatology Conference for PAs and NPs evaluated the safety and efficacy of tazarotene for acne patients with skin of color.